{"record":{"code":"W-00126","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · BR · ESTADO DO MARANHAO - SECRETARIA DE ESTADO DA SAUDE","buyer":"","amount":584531.64,"currency":null,"records":3,"found":"2026-10-04","refs":["ocds-ye9ov3-2973240000106_2025_54","ocds-ye9ov3-2973240000106_2025_77","ocds-ye9ov3-2973240000106_2025_93","2020-06-25","2016-03-23"],"id":"W-00126","html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00126/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00126/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «ESTADO DO MARANHAO - SECRETARIA DE ESTADO DA SAUDE», 3,247,398 BRL (≈ $584,532); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 8; modalidadeNome: Dispensa; modoDisputaId: 5; modoDisputaNom; OCID ocds-ye9ov3-2973240000106_2025_54, ocds-ye9ov3-2973240000106_2025_77, ocds-ye9ov3-2973240000106_2025_93; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · BR · ESTADO DO MARANHAO - SECRETARIA DE ESTADO DA SAUDE",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","584,532",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-00126",null],["Reference","ocds-ye9ov3-2973240000106_2025_54",null],["Reference","ocds-ye9ov3-2973240000106_2025_77",null],["Reference","ocds-ye9ov3-2973240000106_2025_93",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «ESTADO DO MARANHAO - SECRETARIA DE ESTADO DA SAUDE», 3,247,398 BRL (≈ $584,532); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 8; modalidadeNome: Dispensa; modoDisputaId: 5; modoDisputaNom; OCID ocds-ye9ov3-2973240000106_2025_54, ocds-ye9ov3-2973240000106_2025_77, ocds-ye9ov3-2973240000106_2025_93; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"7213f518"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Brazil","iso2":"BR","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":1312,"new_today":0,"on_pages":1312,"full_list":[],"html":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00126/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00126/index.json"}